FOMX Archives - Blue Horseshoe Stocks

Blue Horseshoe Stocks: Closing Out Big Week

Arcadia Biosciences, Inc. RKDA

We tagged RKDA for the first time since May in our extended watchlist yesterday morning, and we were met with a fantastic intraday rip. The stock traded up from a low of 6.93 and managed an intraday high of 10.40 before tapering back into the close. Daytraders could have made a pass at gains of up to 50%

That represents 8-month highs for the stock, a feat which was made possible by the company’s entry into the cannabis space. RKDA will hire a number of agricultural scientists/geneticists to develop ideal strains of hemp. It’s a story we’ll definitely want to follow.

Fresh Options Ideas

We’d like to close out this trading week by once again selecting a group of fresh options ideas to watch today.

Puma Biotech, Inc. PBYI Weekly $33.50-36 Calls*
Foot Locker, Inc. FL Weekly $65-68 Calls*
SPLK Weekly $141-144 Calls*
FNKO 03/15 $22-25 Calls

*Please do not attempt to trade weekly options on a Friday if you are not a seasoned vet trader with disposable funds.

Extended Watchlist:
FLKS, CPRI, PTLA, FOMX, FNKO, OMER, HABT, LXRX, NVCN, CIFS

Blue Horseshoe Stocks: Fresh Options Plays

DSW, Inc. DSW – Recap

Yesterday morning, we decided to highlight the attractive chart setup on DSW with the stock trading at its lowest PPS since May. Despite another tumultuous day for the markets at large, DSW made an early dip-and-rip that savvy traders could have taken advantage of.

We designated the DSW 12/21 $22.50 & $25 Calls and were met with instant success. Both of those contracts produced significant gain opportunities in the first half of the session. The $22.50’s ran from a low of 2.05 and reached as high as 3.50 for a gain of 71% The $25’s fared even better, posting a multi-bag pop from .65-1.50, a 131% move.
_______

Fresh Options Ideas:
Apple Inc. AAPL 01/25 $175-180 Calls
Netflix Inc. NFLX 01/25 $290-300 Calls

Extended Watchlist:
SBS, RARX, FOMX, CORT, ESES, FIVE. SID, ASNA

Blue Horseshoe Stocks: Late Breaking News – PZOO

Pazoo, Inc. PZOO

Yesterday, PZOO continued its trend of producing healthy daily swings, While PZOO did dip briefly below the 50DMA early on, it gave us a chance at a respectable intraday gain, as it has already done several times in the past couple of weeks. The daily range carried the stock from a low of .0074 back up to the penny mark; a 35% move that came on greater than average volume.

We were recently updated on the status of Pazoo partner, MA & Associates, whose cannabis testing facilities still await the first shipments of product for testing. The State of Nevada has delayed the release of regulatory guidelines for growers pertaining to standardized levels of pesticides, pushing the expected date of first delivery to sometime in June. It does give newly appointed marketing and sales executive Michael Tulimero added time to position the company to secure an even larger presence with growers, who are undoubtedly anticipating the regulatory green light from the State as eagerly as anyone. >> READ PR

We want to take note of the significant PR that just hit the wires at 9:45am:

WHIPPANY, N.J., April 15, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (OTC:PZOO), is pleased to announce that as of yesterday, the company has completely repaid the total of its obligations on its Convertible Promissory Notes to LG Capital Funding LLC and Macallan Partners LLC. In addition, Pazoo has given notice of its intention to fully pay off the Convertible Promissory Notes held by Union Capital LLC by the end of next week and Eastmore Capital LLC within the next two weeks. The total of the obligations, repaid and planned for the next two weeks, is approximately $400,000.

Pazoo as a company felt it extremely important to eliminate any conversions of these notes into free trading shares of the company’s common stock. With the tremendous strides recently attained through our 100% subsidiary, Harris Lee, LLC and 40% owned MA & Associates, LLC, Pazoo is currently working towards more traditional financing vehicles. This will also tremendously benefit the company as it will free up tens of millions of reserve shares for the company’s use. >> VIEW FULL PR

Extended Watchlist:
ANGI, CLSN, FOMX, MCP, OSLH, PBR

Blue Horseshoe Stocks: Friday Recap, DRL & More

Reviewing Friday’s Top Picks

iBio, Inc. IBIO

The number one mover from our Friday morning report was undoubtedly IBIO. Our recent observation that increasing concerns over the presence of the Ebola virus on American soil would drive related stocks paid off in spades.

IBIO was among those to get a huge boost on unconfirmed reports that it would aid in government efforts to speed production of the ZMapp experimental Ebola treatment.

The stock would see a low of .89 near the beginning of the session, and ended up running extremely hard into the close, reaching a high of 1.57. That equals out to an intraday surge of 76% but our total possible gains didn’t stop there. The stock continues to roll this morning, having hit a high of 2.76 in the premarket and pushing the total amount of the increase we’ve seen on IBIO since Friday morning to an impressive 210%

Alpha Pro Tech Ltd. APT

Like IBIO, APT was also affected by Ebola fears on Friday, and traded in a less extreme but similar pattern. After seeing a morning low of 5.72, the stock pushed the envelope into the close, reaching a peak of 7.43 for a 30% intraday gain. It is also gapping up bigtime today, with a premarket high of 9.25, which marks a 62% move up from Friday morning’s low.

Doral Financial Corp. DRL

Some of our more seasoned subscribers will certainly remember our coverage of DRL this year. We were waiting to get word on the company’s tax suit against the Puerto Rican governement, and Friday following market close, it was announced that the court has ruled in favor of Doral, which will be due the disputed-over sum of $229M.

As a result of this untraded-upon news, the stock is gapping up like crazy today, to the tune of a 9.46 premarket high, up well over 100% above the low we observed following our initial alert on DRL this summer.

We’ll probably see some selling pressure from profit taking in a situation like this, so we’ll be on the lookout for a potential dip-and-rip scenario to kick off the week.

Extended Watchlist:
AHPI, HEB, NSPH, SMED, FOMX, OBCI,